Fexofenadine/pseudoephedrine explained
| Type: | combo |
| Component1: | Fexofenadine |
| Class1: | Antihistamine |
| Component2: | Pseudoephedrine |
| Class2: | Nasal decongestant |
| Tradename: | Allegra-D |
| Dailymedid: | Fexofenadine hydrochloride and pseudoephedrine hydrochloride |
| Pregnancy Au: | B2 |
| Routes Of Administration: | By mouth |
| Atc Prefix: | R01 |
| Atc Suffix: | BA52 |
| Legal Au: | S3 |
| Legal Ca: | OTC |
| Legal Ca Comment: | [1] |
| Legal Us: | OTC |
| Legal Us Comment: | [2] [3] |
| Kegg: | D10252 |
Fexofenadine/pseudoephedrine, sold under the brand name Allegra-D among others, is a fixed-dose combination medication used for the treatment of nasal congestion and other symptoms of allergies[4] and the common cold. It contains fexofenadine, as the hydrochloride, an antihistamine; and pseudoephedrine, as the hydrochloride, a nasal decongestant.
In 2021, it was the 279th most commonly prescribed medication in the United States, with more than 800,000 prescriptions.[5] [6]
Notes and References
- Web site: Allegra-D Product information . . 25 April 2012 . 2 June 2022.
- Web site: Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release . DailyMed . 3 December 2020 . 2 June 2022.
- Web site: Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release . DailyMed . 30 August 2021 . 2 June 2022.
- Mansfield LE . Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis . Expert Opinion on Pharmacotherapy . 7 . 7 . 941–51 . May 2006 . 16634716 . 10.1517/14656566.7.7.941 . 23165002 .
- Web site: The Top 300 of 2021 . ClinCalc . 14 January 2024 . 15 January 2024 . https://web.archive.org/web/20240115223848/https://clincalc.com/DrugStats/Top300Drugs.aspx . live .
- Web site: Fexofenadine; Pseudoephedrine - Drug Usage Statistics . ClinCalc . 14 January 2024.
